Coronary Artery Bypass Graft News and Research

RSS

Hypertension variability during cardiac surgery may increase risk of death

For patients with hypertension undergoing heart surgery, large variations in blood pressure before, during, and after the operation are associated with an increased risk of death, reports the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Jun 2011

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

23 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).

22 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

22 Jun 2011

Coronary artery bypass graft surgeries have declined by 30% between 2001 and 2008

Between 2001 and 2008, the annual rate of coronary artery bypass graft surgeries performed in the United States decreased by more than 30 percent, but rates of percutaneous coronary interventions did not change significantly, according to a study in the May 4 issue of JAMA.

4 May 2011

New data finds 50% decline in heart surgery wait times in Alberta and BC

New data from the University of Calgary's Faculty of Medicine shows that wait times for a number of heart surgeries have gone down close to 50 per cent in Alberta and British Columbia.

6 Apr 2011

ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI

Oral antiplatelet therapy Effient has been added to the updated clinical practice guidelines as a Class I recommended treatment option for patients undergoing percutaneous coronary intervention fter experiencing heart-related chest pain at rest or non-ST segment elevation myocardial infarction.

30 Mar 2011

Research examines BNP’s role in predicting cardiac events after CABG surgery

More than 250,000 patients undergo coronary artery bypass graft surgery each year in the United States. New research in the April issue of Anesthesiology examines whether the hormone plasma B-type natriuretic peptide helps indicate which patients are at risk of adverse cardiac events after CABG surgery.

24 Mar 2011

Dizziness, nausea and achiness are symptoms of heart attack in females

Dizziness, nausea and achiness – no, these are not symptoms of the flu but signs of a heart attack in females. While heart attacks affect both men and women, the symptoms of a heart attack are surprisingly different between the genders. Virginia Health Information (VHI) this week released its Cardiac Care Report which provides consumers information comparing heart healthcare in Virginia. This year's report reveals women undergoing open heart surgery continued a five year trend of higher than expected readmission rates.

25 Feb 2011

Dual lab tests accurately predict vein graft blood clots in patients during CABG

A team of heart experts at Johns Hopkins has found that dual lab tests of blood clotting factors accurately predict the patients whose blood vessels, in particular veins implanted to restore blood flow to the heart during coronary artery bypass grafting, are more likely to fail or become clogged within six months.

23 Feb 2011

Minor damage to heart muscle during coronary artery bypass grafting associated with increased risk of death

Researchers at Mount Sinai School of Medicine have found that even small amounts of damage to heart muscle during coronary artery bypass grafting (CABG) is associated with an increased risk of death, even among patients who initially do well following surgery. The study is published in the February 9 issue of the Journal of the American Medical Association (JAMA).

9 Feb 2011

Cardiac enzyme elevations following CABG surgery is associated with worse prognosis

Patients who underwent coronary artery bypass graft surgery and had elevated levels of the cardiac enzymes creatine kinase or troponin in the 24 hours following surgery had an associated intermediate and long-term increased risk of death, according to a study in the February 9 issue of JAMA.

9 Feb 2011

Investigators find reduction in STEMI rates, but slight increase in NSTEMI incidence rates

Coronary syndromes vary in severity, ranging from unstable angina, non-ST segment elevation myocardial infarction, to ST-segment elevation myocardial infarction, the most severe diagnosis. Little data exist about changing trends in acute myocardial infarction and whether death rates are increasing or decreasing.

13 Jan 2011

20% of patients who received implantable cardioverter-defibrillators did not meet guidelines for receipt of ICD

A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.

5 Jan 2011

Eighth Annual CTO Summit and Left Main Coronary Interventions Course to be held Feb. 14-16, in New York City

The Eighth Annual Chronic Total Occlusion Summit and Left Main Coronary Interventions Course is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.

4 Jan 2011

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

With value-based purchasing (VBP) now law under health reform, hospitals participating in the nation's largest hospital VBP demonstration are providing lessons learned that can help others save lives and better craft rules to govern the new program.

20 Dec 2010

Viron's Phase 2a trial for VT-111 meets primary, secondary endpoints in ACS patients

Viron Therapeutics Inc. today announced that the results of Viron's Phase 2a trial for VT-111 were published today in Circulation: Cardiovascular Interventions. In the study led by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, VT-111, also known as Serp-1, met both its primary and secondary endpoints of safety and biological activity in Acute Coronary Syndrome patients receiving coronary stents.

17 Dec 2010

Study finds occurrence of infection following surgical procedures

Delaying elective surgical procedures after a patient has been admitted to the hospital significantly increases the risk of infectious complications and raises hospital costs, according to the results of a new study in the December issue of the Journal of the American College of Surgeons.

16 Dec 2010

Enrollment commences in multi-center clinical trial of CorMatrix ECM for Pericardial Closure

CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that Franciscan Alliance/St. Francis Heart Center in Indianapolis, Indiana is the first site to enroll a patient in the multi-center clinical trial of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation.

13 Dec 2010

Cardiac surgeons are trying innovative approaches to traditional open heart surgery

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, cardiac surgeons are trying new innovative approaches to traditional open heart surgery as they try to make coronary artery bypass graft (CABG) procedures less invasive where possible.

3 Dec 2010

Coronary Artery Bypass Graft News and Research

Hypertension variability during cardiac surgery may increase risk of death

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Coronary artery bypass graft surgeries have declined by 30% between 2001 and 2008

New data finds 50% decline in heart surgery wait times in Alberta and BC

ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI

Research examines BNP’s role in predicting cardiac events after CABG surgery

Dizziness, nausea and achiness are symptoms of heart attack in females

Dual lab tests accurately predict vein graft blood clots in patients during CABG

Minor damage to heart muscle during coronary artery bypass grafting associated with increased risk of death

Cardiac enzyme elevations following CABG surgery is associated with worse prognosis

Investigators find reduction in STEMI rates, but slight increase in NSTEMI incidence rates

20% of patients who received implantable cardioverter-defibrillators did not meet guidelines for receipt of ICD

Eighth Annual CTO Summit and Left Main Coronary Interventions Course to be held Feb. 14-16, in New York City

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

Viron's Phase 2a trial for VT-111 meets primary, secondary endpoints in ACS patients

Study finds occurrence of infection following surgical procedures

Enrollment commences in multi-center clinical trial of CorMatrix ECM for Pericardial Closure

Cardiac surgeons are trying innovative approaches to traditional open heart surgery

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News